title: Immune Complex-Mediated Proliferative Glomerulonephritis Induced by Paclitaxel Treatment.
authors.affiliation: Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA; Southern Arizona Veterans Affairs Health Care System; and University of Arizona College of Medicine, Tucson, AZ.
authors.forename: Bilal
authors.initials: B
authors.lastname: Siddiqui
authors.affiliation: Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA; Southern Arizona Veterans Affairs Health Care System; and University of Arizona College of Medicine, Tucson, AZ.
authors.forename: Anna
authors.initials: A
authors.lastname: Greka
authors.affiliation: Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA; Southern Arizona Veterans Affairs Health Care System; and University of Arizona College of Medicine, Tucson, AZ.
authors.forename: Mordecai
authors.initials: M
authors.lastname: Popovtzer
authors.affiliation: Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA; Southern Arizona Veterans Affairs Health Care System; and University of Arizona College of Medicine, Tucson, AZ.
authors.forename: Helmut G
authors.initials: HG
authors.lastname: Rennke
authors.affiliation: Beth Israel Deaconess Medical Center; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School, Boston, MA; Southern Arizona Veterans Affairs Health Care System; and University of Arizona College of Medicine, Tucson, AZ.
authors.forename: Rinath
authors.initials: R
authors.lastname: Jeselsohn
mesh_terms: D000328:Adult; D000936:Antigen-Antibody Complex / Q000378:metabolism*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced*; D006801:Humans; D007105:Immune Complex Diseases / Q000139:chemically induced* / Q000276:immunology; D017239:Paclitaxel / Q000009:adverse effects*
chemical_list: D000936:Antigen-Antibody Complex; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel